Skip to main content

Stories by Judy Stone

What do the UMN and Disney Have in Common?

What do the UMN and Disney Have in Common?

This research ethics series uses the story of Dan Markingson’s participation in a clinical trial of anti-psychotic drugs at the University of Minnesota, his suicide 2004 while participating on the study, and subsequent events as a case study in which to explore various aspects of clinical trial conduct.

November 25, 2013 — Judy Stone
Will Antibiotics Be There When You Need Them? Get Smart

Will Antibiotics Be There When You Need Them? Get Smart

Just in time for “Get Smart about Antibiotics Week,” I had a refreshing experience recently, working in a different rural hospital. Over that week, I didn’t see one patient with “superbugs” other than the occasional MRSA.

November 17, 2013 — Judy Stone

Reflections from a Woman on “Otherness” in Medicine

When Danielle N. Lee, a PhD biologist, was likened to a whore last week for declining to work for free, I was furious. She and Scicurious proposed a series of posts on diversity in science and I reached out, asking if my perspective as a woman physician might be of interest.

October 21, 2013 — Judy Stone
The Checklist Manifesto Meets Clinical Trials–SPIRIT13

The Checklist Manifesto Meets Clinical Trials–SPIRIT13

ClinicalTrials.gov Atul Gawande has made human lapses more understandable, if not acceptable, reminding us that “We miss stuff. We are inconsistent and unreliable because of the complexity of care,” and making the idea of checklists mainstream, rather than a prop for failing memories.

October 8, 2013 — Judy Stone

Requiem for a Hospital

Last night I participated in a requiem for St. Andrews Hospital in Boothbay Harbor, Maine, and for the lost innocence of rural communities.

September 24, 2013 — Judy Stone
Where’s the Real Danger from Infection This Summer?

Where’s the Real Danger from Infection This Summer?

Naegleria fowleri is a summertime villain, scary and sensational, the “Brain-eating Amoeba.” Even the name is villainous. It is an amoeba that lives in fresh water, especially warm water, and is a cause of brain infections, almost always resulting in death.

August 27, 2013 — Judy Stone
uBiome: Ethical Lapse or Not?

uBiome: Ethical Lapse or Not?

uBiome's CEO, Jessica Richman, seems to me to be a great saleswoman who also excels at sounding innocent and playing the misunderstood victim in the ethical controversy surrounding her company.

July 25, 2013 — Judy Stone

Breach of a Community's Trust

Boothbay Harbor, Maine I’m back in Boothbay Harbor for a much anticipated summer vacation, and have promptly become immersed again in the fight over Lincoln County Healthcare (LCH) and MaineHealth’s plan to close St.

July 10, 2013 — Judy Stone

Minnesota Attorney General Confirms They Did Not Exonerate UMN in Markingson Death

Dan and his mom, Mary Weiss This research ethics series uses the story of Dan Markingson’s participation in a clinical trial of anti-psychotic drugs at the University of Minnesota, his suicide 2004 while participating on the study, and subsequent events as a case study in which to explore various aspects of clinical trial conduct.

June 14, 2013 — Judy Stone

Anti-Psychiatry Prejudice? A response to Dr. Lieberman

  Facets of the field Kelly Hills (@rocza) was kind enough to call my attention to the guest post on SciAmMind by Jeffrey Lieberman, incoming president of the American Psychiatric Association (APA). Frankly, I'm appalled by Lieberman's post, especially as it was invited.

May 24, 2013 — Judy Stone

The s**t hits the fan - FDA, INDs, and fecal microbiota transplants

Bristol Stool Chart This weekend, the proverbial s**t hit the fan over the Food & Drug Administration's (FDA) decision to require an Investigational New Drug (IND) application for stool transplants—formally known as “fecal microbiota transplants (FMT)”—for the treatment of C.

May 20, 2013 — Judy Stone

How Not to Run an Op-Ed Page

  Editorial control On Mother’s Day, May 12, ethics Professor Carl Elliott had an Op-Ed published by the Minneapolis Star Tribune, “The University of Minnesota Research Case Needs Scrutiny.”  The Star Tribune began to post comments, the first being:Minnesoda73 May.

May 14, 2013 — Judy Stone

Yahrzeit - Reflections on Dan Markingson's Legacy

Angel of Grief This research ethics series uses the story of Dan Markingson’s participation in a clinical trial of anti-psychotic drugs at the University of Minnesota, his suicide 2004 while participating on the study, and subsequent events as a case study in which to explore various aspects of clinical trial conduct.

May 8, 2013 — Judy Stone

From Tel Aviv to Boston Bombings: Connections at TEDMED

Roller coaster Of the roller coaster of emotions that has marked the past few weeks, personally and for the nation, one talk at TEDMED tied them all together for me, with the theme of our interdependence and how much we can accomplish if we work together.I’d like to share with you several seemingly unrelated events, with a commonality that crystallized for me at TEDMED.Preface: For me, this chapter started a little earlier, with a late night call that my daughter had fallen and was in an Emergency Room several hours from where I live.

April 30, 2013 — Judy Stone

A New University of Minnesota Mystery-The Curious Departure of Mark Rotenberg

All that is necessary for the triumph of evil is that good men do nothing. -Edmund Burke Hear no Evil One month ago, Mike Howard, family friend of Dan Markingson, who committed suicide while participating in a clinical trial at the UMN, launched a petition requesting that Governor Mark Dayton launch an independent investigation of research misconduct in the university’s psychiatry department.

April 11, 2013 — Judy Stone

CDC's "Resistance Nightmare:" A View from the Trenches

Klebsiella Great posts have been written about the “end of antibiotics” and superbugs in a variety of flavors.Yesterday, the CDC⁠ issued an alarming warning about Carbapenem-Resistant Enterobacteriaceae, aka CRE.

March 6, 2013 — Judy Stone